Skip to content

effects of the herbad Zofa ointment in burning therapy

Comparison of therapeutic effects of the herbad Zofa ointment with Silversulfadiazin in burning therapy

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201705119844N5
Enrollment
20
Registered
2017-05-24
Start date
2016-07-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

burns. Burn of second degree of shoulder and upper limb, except wrist and hand

Interventions

Intervention 1: Control group: silver sulfadiazine, topical ointment, three times in a day for two months. Intervention 2: Case group: Zofa, herbal topical ointment, three times in a day for two month
Treatment - Drugs
Control group: silver sulfadiazine, topical ointment, three times in a day for two months.
Case group: Zofa, herbal topical ointment, three times in a day for two months.

Sponsors

Vice chanscellor for research, Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: second degree burn patients hospitalized; patients who decline to participate in research. exclusion criteria: the children; people without consciousness or mental disability; the elderly; pregnant women; immunocompromised patients; patients with drug sensitivity history.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: Before the study, two months after the study. Method of measurement: VAS Scale.

Secondary

MeasureTime frame
Wound healing. Timepoint: Before the study, two months after the study. Method of measurement: Clinical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Arman Javan Rozeghar

Tabriz University of Medical Sceince

Mehamir46@gmail.com+98 41 3340 6612

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026